Psychopathology and Continuous Subcutaneous Insulin Infusion in Type 1 Diabetes

Aim. Continuous subcutaneous insulin infusion (CSII) is used as an option in patients with diabetes failing to multiple daily injections (MDI). Psychological factors may play a relevant role in the failure to attain therapeutic goals in patients on MDI. This could lead to an overrepresentation of ps...

Full description

Bibliographic Details
Main Authors: Francesco Rotella, Caterina Lamanna, Ilaria Dicembrini, Carlo Faravelli, Caterina Calasso, Edoardo Mannucci
Format: Article
Language:English
Published: Hindawi Limited 2013-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1155/2013/672729